Pediatric Use of a C1 Esterase Inhibitor Concentrate for Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry

Conclusions Registry data regarding pnfC1-INH usage support a favorable safety profile in pediatric HAE patients regardless of administration within or outside of a healthcare facility setting.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2016-02, Vol.137 (2), p.AB244-AB244
Main Authors: Martinez-Saguer, Inmaculada, Baker, James W., MD, FAAAAI, Busse, Paula J., MD, FAAAAI
Format: Article
Language:English
Subjects:
Allergy and Immunology
Health facilities
Teenagers
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conclusions Registry data regarding pnfC1-INH usage support a favorable safety profile in pediatric HAE patients regardless of administration within or outside of a healthcare facility setting.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2015.12.985